Supernus (SUPN) EBIT Margin (2022 - 2026)
Supernus Pharmaceuticals' EBIT Margin came in at 9.34% for Q3 2026, up 40.69 percentage points from -31.35% a year earlier and up 35.80 percentage points from the prior quarter.
Powered by 
Analysis
Supernus (SUPN) EBIT Margin (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Supernus Pharmaceuticals reported EBIT Margin of -11.88%, down 6.46 percentage points year-over-year; for FY2025, it came in at -8.66%, down 21.00 percentage points from FY2024.
- EBIT Margin carries a five-year change of -42.04 percentage points (FY2020 to FY2025).
- Going back by year, EBIT Margin was 12.34% in FY2024 (+13.21 pp), -0.87% in FY2023 (-7.78 pp), 6.91% in FY2022 (-7.93 pp) and 14.84% in FY2021 (-18.54 pp).
- The Q3 2026 figure represents the highest quarterly EBIT Margin since Q4 2024.
- Year-over-year, EBIT Margin increased in two of the last seven quarters, with an average year-over-year change of -8.53 percentage points.
- The fastest year-over-year change in EBIT Margin over five years came in Q3 2026 (a gain of 40.69 percentage points), and the weakest in Q3 2025 (a drop of 54.60 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Supernus | 3.39 Bn | 2.50 Bn | 305.00 Mn | 50.56% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 50.56% |
| Jun 30, 2026 | 46.65% |
| Mar 31, 2026 | 43.22% |
| Dec 31, 2025 | 22.63% |
| Sep 30, 2025 | 13.69% |
| Jun 30, 2025 | 23.84% |
| Mar 31, 2025 | 24.81% |
| Dec 31, 2024 | 15.38% |
| Sep 30, 2024 | 11.40% |
| Jun 30, 2024 | -39.46% |
| Mar 31, 2024 | 26.41% |
| Dec 31, 2023 | 20.48% |
| Sep 30, 2023 | -67.53% |
| Jun 30, 2023 | 22.10% |
| Mar 31, 2023 | 22.53% |
| Dec 31, 2022 | -107.05% |
| Sep 30, 2022 | 24.14% |
| Jun 30, 2022 | 28.51% |
API Access
Supernus EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();